Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)
Dermacyd PH_DETINLYN Sweet Flower · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dermacyd PH\_DETINLYN Sweet Flower (Lactic Acid) |
| Name | Type | Description |
|---|---|---|
| Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) | DRUG | - |
Inclusion Criteria: * Integral skin test in the region, * Use of cosmetic product of the same category Exclusion Criteria: * Lactation or gestational risk or gestation * Use of Anti-inflammatory, immunosuppression or anti-histaminic drugs * Atopic antecedent or allergic to cosmetic product * Acti...
Dermacyd PH_DETINLYN Sweet Flower is a small molecule product developed by Sanofi for hygiene use. It is also known as Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid), reflecting lactic acid as its active component. It has been studied in a Phase 3 safety trial conducted in Brazil.
Dermacyd PH_DETINLYN Sweet Flower is developed by Sanofi, which trades under the ticker SNY. Sanofi is the sponsor of the clinical program for this hygiene product.
Dermacyd PH_DETINLYN Sweet Flower has been evaluated in a Phase 3 clinical trial. That trial, NCT00785148, is completed, and no trials for this product are currently active. It is an investigational product rather than a marketed one.
Dermacyd PH_DETINLYN Sweet Flower has been studied in one Phase 3 trial, NCT00785148, titled "Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - Safety." The trial enrolled 31 participants, was conducted in Brazil, and is now completed. It was an uncontrolled safety study in healthy female volunteers aged 10 years and older.
Yes. Dermacyd PH_DETINLYN Sweet Flower is also known as Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid). The parenthetical name refers to lactic acid, the active ingredient in this Sanofi hygiene product. Both names refer to the same investigational asset studied in the Phase 3 safety trial NCT00785148.